» Articles » PMID: 34093766

Naringenin Alleviates Myocardial Ischemia Reperfusion Injury by Enhancing the Myocardial MiR-126-PI3K/AKT Axis in Streptozotocin-induced Diabetic Rats

Overview
Journal Exp Ther Med
Specialty Pathology
Date 2021 Jun 7
PMID 34093766
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Ischemic heart disease (IHD) is a leading cause of death in patients with type 1 diabetes. The key to treating IHD is to restore blood supply to the ischemic myocardium, which inevitably causes myocardial ischemia reperfusion (MI/R) injury. Although naringenin (Nar) prevents MI/R injury, the role of Nar in diabetic MI/R (D-MI/R) injury remains to be elucidated. The PI3K/AKT signaling pathway and microRNA (miR)-126 have previously been shown to serve anti-MI/R injury roles. The present study aimed to investigate the protection of Nar against D-MI/R injury and the role of the miR-126-PI3K/AKT axis. Diabetic rats were treated distilled water or Nar (25 or 50 mg/kg, orally) for 30 days and then exposed to MI/R. The present results revealed that Nar alleviated MI/R injury in streptozotocin (STZ)-induced diabetic rats, as shown below: the reduction myocardial enzymes levels was measured using spectrophotometry, the increase of cardiac viability was detected by MTT assay, the inhibition of myocardial oxidative stress was measured using spectrophotometry and the enhancement of cardiac function were recorded using a hemodynamic monitoring system. Furthermore, Nar upregulated the myocardial miR-126-PI3K/AKT axis in D-MI/R rats. These results indicated that Nar alleviated MI/R injury through upregulating the myocardial miR-126-PI3K/AKT axis in STZ-induced diabetic rats. The current findings revealed that Nar, as an effective agent against D-MI/R injury, may provide an effective approach in the management of diabetic IHD.

Citing Articles

Crosstalk between MiRNAs/lncRNAs and PI3K/AKT signaling pathway in diabetes mellitus: Mechanistic and therapeutic perspectives.

Aghaei-Zarch S Noncoding RNA Res. 2024; 9(2):486-507.

PMID: 38511053 PMC: 10950585. DOI: 10.1016/j.ncrna.2024.01.005.


Effects of Pera Orange Juice and Moro Orange Juice in Healthy Rats: A Metabolomic Approach.

Fujimori A, Ribeiro A, Pereira A, Dias-Audibert F, Tonon C, Dos Santos P Metabolites. 2023; 13(8).

PMID: 37623846 PMC: 10456557. DOI: 10.3390/metabo13080902.


Insight into the Role of the PI3K/Akt Pathway in Ischemic Injury and Post-Infarct Left Ventricular Remodeling in Normal and Diabetic Heart.

Walkowski B, Kleibert M, Majka M, Wojciechowska M Cells. 2022; 11(9).

PMID: 35563860 PMC: 9105930. DOI: 10.3390/cells11091553.

References
1.
Gharravi A, Jafar A, Ebrahimi M, Mahmodi A, Pourhashemi E, Haseli N . Current status of stem cell therapy, scaffolds for the treatment of diabetes mellitus. Diabetes Metab Syndr. 2018; 12(6):1133-1139. DOI: 10.1016/j.dsx.2018.06.021. View

2.
Xiao C, Xia M, Wang J, Zhou X, Lou Y, Tang L . Luteolin Attenuates Cardiac Ischemia/Reperfusion Injury in Diabetic Rats by Modulating Nrf2 Antioxidative Function. Oxid Med Cell Longev. 2019; 2019:2719252. PMC: 6476158. DOI: 10.1155/2019/2719252. View

3.
Meng L, Ma H, Guo H, Kong Q, Zhang Y . The cardioprotective effect of naringenin against ischemia-reperfusion injury through activation of ATP-sensitive potassium channel in rat. Can J Physiol Pharmacol. 2016; 94(9):973-8. DOI: 10.1139/cjpp-2016-0008. View

4.
Zhang B, Jiang H, Chen J, Guo X, Li Y, Hu Q . Nobiletin ameliorates myocardial ischemia and reperfusion injury by attenuating endoplasmic reticulum stress-associated apoptosis through regulation of the PI3K/AKT signal pathway. Int Immunopharmacol. 2019; 73:98-107. DOI: 10.1016/j.intimp.2019.04.060. View

5.
Jha J, Ho F, Dan C, Jandeleit-Dahm K . A causal link between oxidative stress and inflammation in cardiovascular and renal complications of diabetes. Clin Sci (Lond). 2018; 132(16):1811-1836. DOI: 10.1042/CS20171459. View